[EN] SUBSTITUTED PYRAZOLO[3,4-B]PYRIDIN-6-CARBOXYLIC ACIDS AND THEIR USE<br/>[FR] ACIDES PYRAZOLO[3,4-B]PYRIDIN-6-CARBOXYLIQUES SUBSTITUÉS ET LEUR UTILISATION
申请人:ABBVIE S À R L
公开号:WO2017060873A1
公开(公告)日:2017-04-13
The present invention provides for compounds of formula (I), wherein R1, R2, R3, and R4 have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of diseases and conditions mediated and modulated by CFTR, including cystic fibrosis, Sjögren's syndrome, pancreatic insufficiency, chronic obstructive lung disease, and chronic obstructive airway disease. Also provided are pharmaceutical compositions comprised of one or more compounds of formula (I).